/Tag:Bart Barlogie

Celgene Gives $10 Million to Myeloma Institute

March 2, 2015 | The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.

By | March 2nd, 2015|UAMS News, University News|0 Comments

Celgene Gift to UAMS Myeloma Institute for Bart Barlogie Center for Molecular Diagnostics Advances the Course of Human Health for Patients with Multiple Myeloma

LITTLE ROCK –The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.

By | March 2nd, 2015|Media Contact - Taylor/Peel, UAMS News|0 Comments

UAMS Myeloma Institute’s Barlogie Recognized with Lifetime Achievement Award by Israel Cancer Research Fund

LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) Myeloma Institute’s Bart Barlogie, M.D., Ph.D., recently was honored with the Lifetime Achievement Award from the Chicago Chapter of the Israel Cancer Research Fund (ICRF). Bart Barlogie, M.D., Ph.D. Barlogie is a UAMS College of Medicine distinguished professor of medicine and pathology and [...]

By | December 10th, 2014|News Release, UAMS News|0 Comments

UAMS Myeloma Institute’s Barlogie Named Distinguished Professor of Medicine and Pathology

LITTLE ROCK — In recognition of his contributions to ground-breaking translational research and his care of thousands of patients with multiple myeloma, Bart Barlogie, M.D., Ph.D., has been named distinguished professor of medicine and pathology in the College of Medicine of the University of Arkansas for Medical Sciences (UAMS) by resolution of the University of Arkansas Board of Trustees.

By | November 24th, 2014|News Release, UAMS News|0 Comments

Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming to Lead UAMS Myeloma Institute

April 22, 2014 | World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).

By | April 22nd, 2014|UAMS News, University News|0 Comments

Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming from London to Lead UAMS Myeloma Institute

LITTLE ROCK – World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).

By | April 22nd, 2014|News Release, UAMS News|0 Comments

Barlogie Receives Medal from Alma Mater for Myeloma Achievements

The University of Heidelberg in Germany presented a Medal of the Faculty to alumnus and internationally known multiple myeloma pioneer Bart Barlogie, M.D., Ph.D., this summer, honoring his life’s work.

By | September 19th, 2013|UAMS News, University News|0 Comments

Myeloma Institute Celebrates New Home

Oct. 1, 2012 | To Bob Kohler, the new space that houses the Myeloma Institute for Research and Therapy on the University of Arkansas for Medical Sciences (UAMS) campus signifies what his patient experience is all about.

By | October 1st, 2012|UAMS News, University News|0 Comments

UAMS Researchers Uncover Differences in High-Risk Myeloma Cases

July 13, 2010 | Fourteen genes may offer clues as to why multiple myeloma is more aggressive for some patients than for others, say researchers at the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy.

By | July 13th, 2010|UAMS News, University News|0 Comments